Examination about the change of transforming growth factor-beta 1 enzyme in the medical treatment mainly on the diet cure in the cancer patient

Examination about the change of transforming growth factor-beta 1 enzyme in the medical treatment mainly on the diet cure in the cancer patient - Change of transforming growth factor-beta 1 in the cancer patient

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011585

Enrollment

Registered

2013-10-01

Start date

2013-08-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

For the all cancer, regardless of cancer as the underlying disease, a metastatic cancer.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Leave the next House as a first medical examination patient in our House and intend for the case that the combination of the diet cure of our House and the existing cancer cure was started for the first time.

Exclusion criteria

Exclusion criteria: At this House first medical examination, the patient who already received anticancer agent treatment more than 3 Kool is inapplicable.

Design outcomes

Primary

Measure	Time frame
In before and after starting a diet cure, I really measure transforming growth factor-beta 1. I watch it how the later whole body state of the patient, X-rays and CT, image views by the MRI, drawing blood data change as outcome.	—

Countries

Japan

Contacts

Public Contactmasashi yanaki

Clinic of KARASUMA WADA internal medicine

yanakimasashi@yahoo.co.jp090-8804-7526

Outcome results